Ebrahim, Adzmier A.
HRN: 23-44-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/27/2023
08/03/2023
IV
30mg
Q24h
Potential Septic Newborn
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes